Skip to main content

Day: September 29, 2025

Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates

Last patient last visit (LPLV) milestone in AFFIRM-1 Phase 3 trial of BNC-210 in social anxiety disorder (SAD) achieved; topline readout anticipated in early Q4 2025 Cash runway extended through fiscal Q2 2027 BURLINGTON, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) — Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments for neuropsychiatric disorders, today reported its financial results for its fiscal year ended June 30, 2025, and provided recent business updates. “It is an exciting time for Neuphoria as we rapidly approach topline data from our AFFIRM-1 Phase 3 study of BNC-210 in social anxiety disorder, which is anticipated early in the fourth quarter of this year,” said Spyros Papapetropoulos, M.D., Ph.D., President and CEO of Neuphoria....

Continue reading

Precision Optics Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Conference Call Scheduled for today, September 29, 2025, at 5:00pm ET Company introduces fiscal year 2026 Revenue and Adjusted EBITDA guidance Company appoints new Chief Operating Officer GARDNER, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) — Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced operating results on an unaudited basis for its fourth quarter and fiscal year 2025 for the period ended June 30, 2025. Q4 2025 Financial Highlights (3 Months Ended June 30, 2025):Revenue was $6.2 million, a new quarterly record, compared to $4.7 million in the same quarter of the previous fiscal year and compared to $4.2 million in the most recent sequential quarter, representing growth of approximately 48%. Production...

Continue reading

Concorde International Group Reports 11% Year-over-Year Revenue Growth to $6.0 million for H1 of 2025

Gross profit increased 30% year-over-year to $1.9 million for H1 2025, compared to $1.5 million for the same period last year Gross margin increased 450 basis points to 31.5% for H1 2025, compared to 27.0% for the same period last year SINGAPORE, Sept. 29, 2025 (GLOBE NEWSWIRE) — Concorde International Group Ltd. (NASDAQ: CIGL) (“Concorde” or the “Company”), an integrated security services provider that combines physical manpower and innovative technology to deliver effective security solutions, today announced financial results and provided a business update for the first half of 2025 (H1 2025) ended June 30, 2025. H1 2025 Financial HighlightsRevenue increased by approximately 11%, to approximately $6.0 million for H1 2025, compared to approximately $5.4 million for H1 2024 Gross profit increased by approximately 30% to $1.9...

Continue reading

Magnera Announces Strategic Exit from Argentina as Part of Project CORE Transformation

CHARLOTTE, N.C., Sept. 29, 2025 (GLOBE NEWSWIRE) — As part of its ongoing transformation initiative (Project CORE), Magnera today announced a key step in optimizing operations and aligning resources with long-term growth priorities. Effective immediately, production will halt and operations at the company’s Pilar, Argentina site will begin winding down. The company will continue to fulfill pre-existing commitments out of the site and ensure continuity for customers during this transition. The closure is part of Project CORE (Capacity Optimization and Resource Efficiency), a company-wide program introduced in Magnera’s most recent earnings release. Project CORE is designed to streamline Magnera’s global footprint, enhance operational agility, and deliver greater value to customers and partners. “This was not a decision taken lightly,”...

Continue reading

Creative Global Technology Holdings Limited Announces Fiscal 2025 First Half Financial Results

HONG KONG, Sept. 29, 2025 (GLOBE NEWSWIRE) — Creative Global Technology Holdings Limited (Nasdaq: CGTL) (the “Company”, “we”, “our”, “us” or “CGTL”), a company which recycles consumer electronic devices headquartered in Hong Kong, today announced its unaudited financial results for the six months ended March 31, 2025. First Half Financial Results for Fiscal 2025 Compared to First Half Financial Results for Fiscal 2024Revenues were $12.2 million for the six months ended March 31, 2025, a 40.4% decrease from $20.5 million for the six months ended March 31, 2024; Gross profit was $1.5 million for the six months ended March 31, 2025, or 12.6% of revenues compared to $2.7 million, or 13.1% of revenues for the six months ended March 31, 2024; Net loss was $15.3million for the six months ended March 31, 2025, compared to net income...

Continue reading

Megan Holdings Limited Announces Closing of $5 Million Initial Public Offering

Malaysia, Kuala Lumpur, Sept. 29, 2025 (GLOBE NEWSWIRE) — Megan Holdings Limited (the “Company” or “Megan”), a Malaysia-based company principally engaged in the development, construction, and maintenance of aquaculture farms and related works, today announced the closing of its initial public offering (the “Offering”) of 1,250,000 ordinary shares, par value US$0.0001 per share, (“Ordinary Shares”), at a public offering price of US$4.00 per Ordinary Share. The Company has granted a 45-day option to the underwriters to purchase up to 187,500 additional Ordinary Shares solely to cover over-allotments, if any. The Ordinary Shares began trading on the Nasdaq Capital Market on September 26, 2025 under the ticker symbol “MGN.” The Company received aggregate gross proceeds of US$5 million from the Offering, before deducting underwriting...

Continue reading

American Rebel Holdings, Inc. (NASDAQ: AREB) and TSR Nitro Celebrate the American Rebel Beer Dodge Hellcat Victory at NHRA Midwest Nationals—Matt Hagan Wins Big in St. Louis

Matt Hagan Powers American Rebel to Victory at NHRA Midwest Nationals—American Rebel Beer Dodge Hellcat Claims First Win of 2025 Nashville, TN, Sept. 29, 2025 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) American Rebel Beverages, and American Rebel Light Beer (www.americanrebelbeer.com) congratulate Matt Hagan who drove and powered the American Rebel Funny Car to victory at the NHRA Midwest Nationals in St. Louis, Missouri. The win marks a defining moment in the Countdown to the Championship and reinforces American Rebel’s growing presence in the sport — both on the track and in the hearts of fans. American Rebel Beer was the primary sponsor for the four-time NHRA Funny Car world champion Matt Hagan, who drove the American Rebel Beer Dodge//SRT Hellcat to victory at the 14th Annual NHRA Midwest Nationals. The...

Continue reading

Lesaka’s Final FY2025 Results: Delivers on FY2025 Profitability Guidance, Reaffirms FY2026 Profitability & Net Revenue Outlook, and Sets FY2026 Profitability per Share Guidance, reflecting more than 100% Year-on-Year Growth

JOHANNESBURG, Sept. 29, 2025 (GLOBE NEWSWIRE) — Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) today released results for the fourth quarter (“Q4 2025”) and full year of fiscal 2025 (“FY2025”). FY2025 performance:All growth rates are year-on-year between FY2025 and FY2024.Revenue of $659.7 million (ZAR 12.0 billion) up 14% in ZAR. Net Revenue (a non-GAAP measure) of $328.7 million (ZAR 5.3 billion), up 38% in ZAR. Net Loss of $87.5 million (ZAR 1.6 billion), up 386% in ZAR largely due to inclusion of a tax adjusted $49.3 million (ZAR 897.6 million) non-operating, non-cash charge relating to a change in fair value and sale of MobiKwik (a non-core asset), a tax adjusted non-cash charge from impairment losses of $18.4 million (ZAR 326.2 million) and once-off transaction costs of $17.8 million (ZAR 321.9 million). Group Adjusted...

Continue reading

SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

TEL AVIV, Israel, Sept. 29, 2025 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (the “Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that on September 25, 2025, the stockholders of N2OFF, Inc. (NASDAQ: NITO) (“N2OFF”) voted on and approved, among other things, the proposed acquisition of SciSparc’s majority owned subsidiary, MitoCareX Bio Ltd. (“MitoCareX”). This important milestone, achieved at N2OFF’s special meeting of stockholders held on September 25, 2025, clears a key path for the completion of the Acquisition, which would result in MitoCareX becoming a wholly owned subsidiary of N2OFF. MitoCareX is focusing on the development of novel therapies for hard-to-treat...

Continue reading

Progress Software Announces Third Quarter 2025 Financial Results

Annualized Recurring Revenue (“ARR”) of $849 million Grew 47% year-over-yearRevenue of $250 million Grew 40% year-over-yearRaises Full Year Guidance for Revenue, Earnings Per Share, and Cash Flow BURLINGTON, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) — Progress Software (Nasdaq: PRGS), the trusted provider of AI-powered digital experience and infrastructure software, today announced financial results for its fiscal third quarter ended August 31, 2025. Third Quarter 2025 Highlights:Revenue of $250 million increased 40% year-over-year on an actual currency basis and 38% on a constant currency basis. Annualized Recurring Revenue (“ARR”) of $849 million increased 47% year-over-year on a constant currency basis. Operating margin was 18% and non-GAAP operating margin was 40%. Diluted earnings per share was $0.44...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.